1	Surfactant	surfactant	_	_	_	_	_	_	_
2	protein	protein	_	_	_	_	_	_	_
3	A	a	_	_	_	_	_	_	_
4	activates	activate	_	_	_	_	_	_	_
5	NF-kappa	NF-kappa	_	_	_	_	_	_	_
6	B	B	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	THP-1	thp-1	_	_	_	_	_	_	_
10	monocytic	monocytic	_	_	_	_	_	_	_
11	cell	cell	_	_	_	_	_	_	_
12	line	line	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	expression	expression	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	many	many	_	_	_	_	_	_	_
5	genes	gene	_	_	_	_	_	_	_
6	for	for	_	_	_	_	_	_	_
7	which	which	_	_	_	_	_	_	_
8	products	product	_	_	_	_	_	_	_
9	are	be	_	_	_	_	_	_	_
10	involved	involve	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	inflammation	inflammation	_	_	_	_	_	_	_
13	is	be	_	_	_	_	_	_	_
14	controlled	control	_	_	_	_	_	_	_
15	by	by	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	transcriptional	transcriptional	_	_	_	_	_	_	_
18	regulator	regulator	_	_	_	_	_	_	_
19	nuclear	nuclear	_	_	_	_	_	_	_
20	factor	factor	_	_	_	_	_	_	_
21	(	(	_	_	_	_	_	_	_
22	NF)-kappa	NF)-kappa	_	_	_	_	_	_	_
23	B.	B.	_	_	_	_	_	_	_
24	Because	because	_	_	_	_	_	_	_
25	surfactant	surfactant	_	_	_	_	_	_	_
26	protein	protein	_	_	_	_	_	_	_
27	(	(	_	_	_	_	_	_	_
28	SP	SP	_	_	_	_	_	_	_
29	)	)	_	_	_	_	_	_	_
30	A	A	_	_	_	_	_	_	_
31	is	be	_	_	_	_	_	_	_
32	involved	involve	_	_	_	_	_	_	_
33	in	in	_	_	_	_	_	_	_
34	local	local	_	_	_	_	_	_	_
35	host	host	_	_	_	_	_	_	_
36	defense	defense	_	_	_	_	_	_	_
37	in	in	_	_	_	_	_	_	_
38	the	the	_	_	_	_	_	_	_
39	lung	lung	_	_	_	_	_	_	_
40	and	and	_	_	_	_	_	_	_
41	alters	alter	_	_	_	_	_	_	_
42	immune	immune	_	_	_	_	_	_	_
43	cell	cell	_	_	_	_	_	_	_
44	function	function	_	_	_	_	_	_	_
45	by	by	_	_	_	_	_	_	_
46	modulating	modulate	_	_	_	_	_	_	_
47	the	the	_	_	_	_	_	_	_
48	expression	expression	_	_	_	_	_	_	_
49	of	of	_	_	_	_	_	_	_
50	proinflammatory	proinflammatory	_	_	_	_	_	_	_
51	cytokines	cytokine	_	_	_	_	_	_	_
52	as	as	_	_	_	_	_	_	_
53	well	well	_	_	_	_	_	_	_
54	as	as	_	_	_	_	_	_	_
55	surface	surface	_	_	_	_	_	_	_
56	proteins	protein	_	_	_	_	_	_	_
57	involved	involve	_	_	_	_	_	_	_
58	in	in	_	_	_	_	_	_	_
59	inflammation	inflammation	_	_	_	_	_	_	_
60	,	,	_	_	_	_	_	_	_
61	we	we	_	_	_	_	_	_	_
62	hypothesized	hypothesize	_	_	_	_	_	_	_
63	that	that	_	_	_	_	_	_	_
64	SP-A	SP-A	_	_	_	_	_	_	_
65	exerts	exert	_	_	_	_	_	_	_
66	its	its	_	_	_	_	_	_	_
67	action	action	_	_	_	_	_	_	_
68	,	,	_	_	_	_	_	_	_
69	at	at	_	_	_	_	_	_	_
70	least	least	_	_	_	_	_	_	_
71	in	in	_	_	_	_	_	_	_
72	part	part	_	_	_	_	_	_	_
73	,	,	_	_	_	_	_	_	_
74	via	via	_	_	_	_	_	_	_
75	activation	activation	_	_	_	_	_	_	_
76	of	of	_	_	_	_	_	_	_
77	NF-kappa	NF-kappa	_	_	_	_	_	_	_
78	B.	B.	_	_	_	_	_	_	_
79	We	we	_	_	_	_	_	_	_
80	used	use	_	_	_	_	_	_	_
81	gel	gel	_	_	_	_	_	_	_
82	shift	shift	_	_	_	_	_	_	_
83	assays	assay	_	_	_	_	_	_	_
84	to	to	_	_	_	_	_	_	_
85	determine	determine	_	_	_	_	_	_	_
86	whether	whether	_	_	_	_	_	_	_
87	SP-A	SP-A	_	_	_	_	_	_	_
88	activated	activate	_	_	_	_	_	_	_
89	NF-kappa	NF-kappa	_	_	_	_	_	_	_
90	B	B	_	_	_	_	_	_	_
91	in	in	_	_	_	_	_	_	_
92	the	the	_	_	_	_	_	_	_
93	THP-1	thp-1	_	_	_	_	_	_	_
94	cell	cell	_	_	_	_	_	_	_
95	line	line	_	_	_	_	_	_	_
96	,	,	_	_	_	_	_	_	_
97	a	a	_	_	_	_	_	_	_
98	human	human	_	_	_	_	_	_	_
99	monocytic	monocytic	_	_	_	_	_	_	_
100	cell	cell	_	_	_	_	_	_	_
101	line	line	_	_	_	_	_	_	_
102	.	.	_	_	_	_	_	_	_

1	Activation	Activation	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	NF-kappa	NF-kappa	_	_	_	_	_	_	_
4	B	B	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	THP-1	thp-1	_	_	_	_	_	_	_
7	cells	cell	_	_	_	_	_	_	_
8	by	by	_	_	_	_	_	_	_
9	SP-A	SP-A	_	_	_	_	_	_	_
10	doses	dose	_	_	_	_	_	_	_
11	as	as	_	_	_	_	_	_	_
12	low	low	_	_	_	_	_	_	_
13	as	as	_	_	_	_	_	_	_
14	1	1	_	_	_	_	_	_	_
15	microgram/ml	microgram/ml	_	_	_	_	_	_	_
16	occurred	occur	_	_	_	_	_	_	_
17	within	within	_	_	_	_	_	_	_
18	30	30	_	_	_	_	_	_	_
19	min	min	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	SP-A	SP-A	_	_	_	_	_	_	_
22	treatment	treatment	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	peaked	peak	_	_	_	_	_	_	_
25	at	at	_	_	_	_	_	_	_
26	60	60	_	_	_	_	_	_	_
27	min	min	_	_	_	_	_	_	_
28	,	,	_	_	_	_	_	_	_
29	and	and	_	_	_	_	_	_	_
30	then	then	_	_	_	_	_	_	_
31	declined	decline	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	activation	activation	_	_	_	_	_	_	_
3	is	be	_	_	_	_	_	_	_
4	inhibited	inhibit	_	_	_	_	_	_	_
5	by	by	_	_	_	_	_	_	_
6	known	known	_	_	_	_	_	_	_
7	inhibitors	inhibitor	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	NF-kappa	NF-kappa	_	_	_	_	_	_	_
10	B	B	_	_	_	_	_	_	_
11	or	or	_	_	_	_	_	_	_
12	by	by	_	_	_	_	_	_	_
13	simultaneous	simultaneous	_	_	_	_	_	_	_
14	treatment	treatment	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	cells	cell	_	_	_	_	_	_	_
18	with	with	_	_	_	_	_	_	_
19	surfactant	surfactant	_	_	_	_	_	_	_
20	lipids	lipid	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	Moreover	moreover	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	NF-kappa	NF-kappa	_	_	_	_	_	_	_
5	B	B	_	_	_	_	_	_	_
6	inhibitors	inhibitor	_	_	_	_	_	_	_
7	blocked	block	_	_	_	_	_	_	_
8	SP-A-dependent	sp-a-dependent	_	_	_	_	_	_	_
9	increases	increase	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	tumor	tumor	_	_	_	_	_	_	_
12	necrosis	necrosis	_	_	_	_	_	_	_
13	factor-alpha	factor-alpha	_	_	_	_	_	_	_
14	mRNA	mrna	_	_	_	_	_	_	_
15	levels	level	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	observations	observation	_	_	_	_	_	_	_
3	suggest	suggest	_	_	_	_	_	_	_
4	a	a	_	_	_	_	_	_	_
5	mechanism	mechanism	_	_	_	_	_	_	_
6	by	by	_	_	_	_	_	_	_
7	which	which	_	_	_	_	_	_	_
8	SP-A	SP-A	_	_	_	_	_	_	_
9	plays	play	_	_	_	_	_	_	_
10	a	a	_	_	_	_	_	_	_
11	role	role	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	pathogenesis	pathogenesis	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	some	some	_	_	_	_	_	_	_
17	lung	lung	_	_	_	_	_	_	_
18	conditions	condition	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	point	point	_	_	_	_	_	_	_
21	to	to	_	_	_	_	_	_	_
22	potential	potential	_	_	_	_	_	_	_
23	therapeutic	therapeutic	_	_	_	_	_	_	_
24	measures	measure	_	_	_	_	_	_	_
25	that	that	_	_	_	_	_	_	_
26	could	could	_	_	_	_	_	_	_
27	be	be	_	_	_	_	_	_	_
28	used	use	_	_	_	_	_	_	_
29	to	to	_	_	_	_	_	_	_
30	prevent	prevent	_	_	_	_	_	_	_
31	SP-A	SP-A	_	_	_	_	_	_	_
32	induced	induced	_	_	_	_	_	_	_
33	inflammation	inflammation	_	_	_	_	_	_	_
34	in	in	_	_	_	_	_	_	_
35	the	the	_	_	_	_	_	_	_
36	lung	lung	_	_	_	_	_	_	_
37	.	.	_	_	_	_	_	_	_

